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Introduction
One of the most important components of life are large molecules called
proteins, used for carrying out an immense variety of biological functions. In
addition to their main structure, some proteins have additional, nonprotein
components that are necessary for their function. One example of this is the
compound heme (Figure 1), which is integrated into the protein structure and used
as a binding site. A well-known example of a heme protein is hemoglobin, a protein
in the blood that is responsible for transporting oxygen from the lungs into other
parts of the body. The heme compound contains an iron atom in the center, and this
is where the oxygen actually binds. However, there are many other protein types
that contain a heme molecule, including a specific subset that was the focus of this
research. Thiolate-ligated heme proteins contain a heme group that is bound to
sulfur in the amino acid cysteine. Included in this group are Type II proteins, which
undergo a ligand switch. A ligand is a molecule that binds to another molecule. In
this protein, the ligand is an amino acid in the protein, and the iron in the heme is
the molecule that it binds to. A ligand switch occurs when the original amino acid
that is attached to the heme dissociates and is replaced by a second amino acid. For
most Type II proteins, the cysteine will be displaced by a neutral ligand, and this
controls protein activation and function (Figure 2). The exact mechanism of the
ligand switch and how it controls function is not well known in this protein type,
and these proteins contain complex structures that are difficult to work with and
study.
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Purpose
Type II proteins are important because they are implicated in a variety of
necessary biological functions, including the binding of gaseous molecules,
metabolic processes, and the regulation of circadian rhythms (Table 1). Learning
more about the details as to how these biological activities actually work will make
it easier to understand how to repair them in various disease states. The purpose of
this research was to create a simpler model of Type II proteins in order to study the
ligand switch using cytochrome c (Figure 3). Cytochrome c was chosen because it is
small, easy to work with, and relatively easy to mutate. It also already has a built-in
mechanism for a ligand switch, making it the ideal candidate for this protein model.
Mutating cytochrome c into a model Type II protein and learning more about how
the ligand switch controls function may generate new insight into how the
corresponding ligand switch works in more complex proteins.

Literature Review
The discovery of proteins with a ligand switch involving a sulfur-containing
amino acid is relatively new. Omura published a review article in 2005 that
describes several mechanisms behind some of these proteins that had just been
discovered, including CooA and CBS. CooA is a transcription factor specific to a
bacterium, R. rubrum, which is able to use this protein to sense the local
environment and detect the presence of carbon monoxide. The organism can then
manufacture enzymes that allow it to metabolize and survive using carbon
monoxide in anaerobic (oxygen deficient) conditions. CBS, or cystathionine beta-
synthase, is an enzyme present in many organisms. However, the exact function of
2

the heme in this important protein is unknown. Studying the mechanisms behind
the ligand switch, which greatly affects enzyme activity, may give some insight to
how this enzyme is regulated in humans and other eukaryotic organisms.
As more thiolate-ligated proteins are discovered (Table 1), research has
shown insight into several patterns related to how these proteins function. Igarashi
(et al.) explored several key points about these protein types in an article published
in 2008. An important aspect of this article that is relevant to the creation of a
cytochrome c model is the description of the changing oxidation states of the iron in
the heme. In these proteins, iron can be in either the +2 or +3 oxidation state, and
this can be dependent on the ligands bound to the heme. The proteins can have
different properties depending on the state of the iron; therefore, this concept is
crucial to understanding the overall mechanism of the ligand switch.
When introducing mutations to a protein, it is important to consider the
implications of the changes being made to the structure. A 2012 article by Shimuzu
lists several important characteristics of heme sensor proteins that must be taken
into consideration when mutating amino acids in this type of protein. Some features
of key importance in this research include the binding strength of the heme to the
protein, the oxidation state of the iron, and the stabilizing effects of amino acids
surrounding the heme.
In addition to finding information about ligand switches in known thiolate-
ligated heme proteins, it was necessary to obtain more background information
about the protein that will be used for the model, cytochrome c. Cherney and
Bowler’s article, published in 2010, gives an excellent description of the ligand
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switch that is already part of this protein’s normal functioning. The fact that that
cytochrome c already had a built-in ligand switch mechanism was one of the key
reasons this protein was chosen to attempt to model the more complex Type II
proteins.
The primary literature articles provided good background information for
several different components of the research to be undertaken, but there were two
additional sources of information that pertained more directly to this project. These
were the introductory chapters of dissertations from previous graduate students
that had worked on similar projects in a lab at the University of Wisconsin-Madison.
The first dissertation was written in 2006 by Samuel Pazicni. The first
chapter of the dissertation gave a very useful explanation of what a thiolate-ligated
heme protein is. It also explained the differences between Type I and Type II
proteins. Essentially, the defining factor of a Type II protein is that the “cysteine
ligand is exchange labile,” meaning it will readily dissociate and switch with a
different ligand. In these proteins there is what is known as a six-coordinate iron,
because the iron in the heme forms six bonds, four with the nitrogens in the
porphyrin ring, and two with the protein amino acids. A Type I protein will typically
have only one ligand to the protein, meaning it is five-coordinate. In addition to
explaining the differences between the two types, several examples of each protein
are given, along with what is known about their functions. Two key proteins that are
discussed in detail (mentioned earlier in this introduction) include CooA, one of the
proteins with a better-understood ligand switch, and human cystathionine β-
synthase, or hCBS. This latter protein is important because it is not yet entirely
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understood as to how the ligand switch affects the functioning of the protein, and
problematic mutations in hCBS can lead to disease states in humans. Learning more
about it could lead to understanding more about a protein that can have important
biological functions. The second part of this introductory chapter gives more details
about the specific spectroscopic characteristics of these proteins, and the
differences between them in oxidized and reduced states. Further elaboration about
the UV-Visible spectroscopy done for this research can be found in the methodology
section.
The second dissertation was written in 2008 by Katherine A. Marvin. Most of
the information in the first chapter was similar to the previous dissertation,
including the descriptions of the known differences between Type I and Type II
proteins, specific protein examples, and various spectroscopic characteristics. Even
though the content was analogous to the above information, it was a good
reinforcement of the basic characteristics of the proteins being studied in this
research, and good background information is essential to working effectively.
Overall the various literature sources gave a great deal of useful insight as to
how ligand switches work, as well as specific characteristics of Type II proteins. It
was important to learn more about the various states of iron in the heme and how
this would be implicated by spectral changes of the protein. Finally, it was crucial to
learn more about cytochrome c, the protein to be used as a model for this research.
Gaining background information about this subject led to the development of a
suitable research question to explore for this thesis.

5

Research Questions to Be Answered
The primary question to be answered during this research project was: what
are the necessary mutations that must be made to cytochrome c to allow it to
function as a Type II protein model? These mutations needed to be identified and
carried out in a way that was reproducible in order for this protein to be a valid
model. Although progress has been made towards creating this model, there are still
inconsistencies that need to be corrected before using it to study the mechanisms of
the ligand switch. Once this question is answered and the protein behaves in a
manner that is consistent with a Type II protein, the protein can then be used to
study how the ligand switch controls the activation of the protein. There were
several mutations that were definitely necessary to make a proper protein model.
However, after testing of a proper ligand switch mechanism showed that the
negative control also underwent a ligand switch when it was not supposed to, it
became clear that additional mutations are necessary for the model. Because of this
unexpected behavior for the negative control, a new research question had to be
developed: what chemical group is the negative control protein using in order to
ligand switch, and how can it be eliminated to create a valid model? This question
became the primary question for this project, and the exact chemical group used in
the ligand switch of the negative control protein remains elusive at this time.
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Methodology
PCR
The first stage in the development of a new protein variant is to mutate the
DNA that codes for the protein structure. This was done using polymerase chain
reaction, or PCR. The DNA of the original protein was used as a template, and DNA
primers were designed to mutate specific amino acid sites on the DNA. This newly
mutated DNA was “copied” using a thermocycler. A thermocycler has three stages of
differing temperatures needed to synthesize many copies of the newly mutated
DNA. The stages are denaturing, in which the two strands of DNA are separated,
annealing, when the primers can bind to the now separate strands of parent DNA,
and elongation, in which the DNA polymerase enzyme builds up the new strands of
DNA using the provided DNA building blocks. The enzyme used for elongating the
DNA was PfuUltra Polymerase enzyme, which is a high fidelity enzyme, since it
“proofreads” as it synthesizes new DNA. The method used involved heating the PCR
reaction mixture to a denaturing temperature of 95°C, cooling it to an annealing
temperature of 55°C, and then slightly heating it to an elongation temperature of
68°C. This temperature cycle was repeated 20 times, and then the reaction was
cooled to 4°C. After the reaction, 1µl of DpnI enzyme was added to the PCR tube, and
it was left in a water bath set at 37°C for one hour. This enzyme cleaves any DNA
with extra methyl groups, which will only be true of the template DNA. Thus, for the
next steps only newly synthesized DNA will be relevant. Afterwards the DNA was
stored in the freezer at -20°C. Before proceeding, the new DNA needed to be tested
to ensure that the mutation was successful.
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Media Bottle Preparation
The components of the growth plates used for bacterial transformation are
stored in two separate bottles and combined immediately before the plates are
poured. The first is 2xLC media, which is 2g bacto-tryptone, 1g yeast extract, and
1.2g NaCl. These powders were weighed out and placed in glass bottles, and then
100mL of distilled water was added. The second component of the plate media is
3% agar, a solidifying agent. For this, 3g of bacto-agar was added to a glass bottle,
and 100mL of distilled water was added. Both of these bottles were then autoclaved
in order to sterilize them. The sterilized components could then be left on the bench
indefinitely.
Growth Plate Preparation
The plates were prepared using 100mL of 2xLC media and 100mL of 3%
agar. This makes a total of eight plates. The agar was microwaved until it was
completely liquefied, and then poured into the 2xLC media. The solution was mixed
slightly until it was warm, but not hot. 200µl of the antibiotic ampicillin (a
100mg/mL stock) was added, and the solution was swirled to mix. A 25mL
graduated pipet was used to add 25mL of media to each plate. The final antibiotic
concentration in the plates was 100µg/mL. The plates were allowed to dry for about
10 minutes, then inverted and placed in a 35.5°C incubator overnight to dry a little
further. Afterwards the plates were stored at 4°C until they were used.
Transformation
The DNA from the PCR was incorporated into E. coli cells using the heat
shock method. DH5α cells (genetically altered to enhance DNA production) that
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were already competent to taking up foreign DNA were purchased. First, cells and
DNA were combined in a sterile reaction tube. The tubes with the cells and DNA
were left to sit on ice for 30 minutes. This gave the DNA time to associate with the
cells, which would make it easier to get into the cells. After 30 minutes, the cells
were placed in a water bath set at 42°C for 45 seconds. This process creates
openings in the cell wall for the foreign DNA to pass through. The cells were then
removed from the heat, and 250µl of SOC broth was added to each tube. This is a
media that provides many vital nutrients for the cells to promote growth. The tubes
were placed in an automated shaker, set at 37°C and 200rpm for one hour. The
agitation of the cells continually oxygenates the solution, distributes the nutrients,
and allows the cells to stay suspended in the solution so they don’t settle to the
bottom. After the one-hour growth in the shaker, 130µl of cells from each tube were
placed on an LC-Amp growth plate. These plates also have the antibiotic ampicillin,
which means that only the ampcillin resistant bacteria from the PCR will be able to
grow on the plate. Each transformation tube is split to make 2 LC-Amp plates. The
cells were pipetted onto the plate and then spread over the entire surface area using
a glass spreader. The spreader was sterilized with ethanol and flame between each
plating. The cells were incubated and left to grow overnight at about 35.5°C until
individual bacteria colonies were observed.
Liquid Cultures
Once the LC-Amp plates had E. coli growth, several individual colonies were
chosen for liquid cultures. The cultures were prepared by using a graduated pipet to
add 10mL of 2xLC media to a sterile 125mL Erlenmeyer flask. 10µl of 100ng/µl
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ampicillin was added to each flask and they were swirled to mix. The colonies for
each culture were selected and marked on the plate. An ideal colony was one that
was not touching any other colonies and had a relatively uniform size and boundary
compared to the other colonies on that particular plate. Using forceps, a sterile
toothpick was touched to the marked colony and placed in the flask. The flasks were
placed in the shaker at 37°C and 200rpm (revolutions per minute) to grow
overnight.
Plasmid Purification
After making liquid cultures, the cells needed to be lysed and the DNA
extracted and purified. The flasks were removed from the shaker and placed on ice.
Disposable pipets were used to add the cultures to 1.5mL sterile tubes until the
tubes were almost full. The tubes were balanced and placed in the microcentrifuge
for 1 minute at 11,000rpm. This caused a small cell pellet to form at the bottom of
each tube, with the cell-free liquid media at the top. This media was poured off and
more of the liquid culture was added to the tube. These steps were repeated until all
of the cells had been collected in a pellet at the bottom of the tubes.
At this stage, the Wizard Plus Minipreps DNA Purification System was used to
lyse the cells and extract the plasmid. This is a kit with all of the necessary solutions
needed for the procedure. First 250µl of Cell Resuspension Solution was added, and
the tubes were left to sit for five minutes. The cells were then vortexed until the cell
pellets were completely gone, meaning the cells were all resuspended. Next, 250µl
of Cell Lysis Solution was added and the tubes were inverted four times to mix,
followed by the addition of 10µl of Alkaline Protease solution and four more
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inversions. These steps caused the cells to lyse and the proteins released into the
solution to be degraded by the alkaline protease enzyme. The tubes were incubated
for five minutes at room temperature. 350µl of Neutralization Solution was added
and the tubes were again inverted four times. This step caused the remaining
protein in the solution to precipitate. The tubes were placed in the microcentrifuge
and spun for 10 minutes at maximum speed, 14,800rpm, causing the protein to form
a pellet in the bottom of the tube.
For the next stage of the purification process, a special tube was used for
each sample. This tube had two components, a spin column, which the plasmid DNA
was able to bind to, and a collection tube, in which the rest of the solution would be
filtered into. The spin column was inserted into the collection tube. When the cells
were done in the microcentrifuge, there was a protein pellet at the bottom and
liquid at the top containing the dissolved DNA. The liquid was poured into the spin
column, and the pellet was disposed of. The spin column was centrifuged at
maximum speed for one minute. The liquid had passed through the spin column and
collected in the lower tube. The spin column was removed and the liquid was
poured out in the waste, and the spin column was reinserted into the collection
tube. At this point the DNA was bound to the filter in the spin column. The column
was washed by adding 750µl of Wash Solution, centrifuging for one minute and
discarding the flowthrough. The wash step was repeated, this time with 250µl of
Wash Solution. After the second wash flowthrough had been discarded, the spin
column and collection tube were centrifuged for two minutes at maximum speed in
order to ensure that there was no more wash solution associated with the upper
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spin column. The spin column was transferred to a sterile 1.5mL tube for each
sample. 50µl of nuclease-free water was added to each spin column, and the tubes
sat for one minute to allow the DNA on the filter to dissolve. The spin column and
tube were then centrifuged for one minute at maximum speed. This step caused the
plasmid to flow through the spin column and collect in the 1.5mL tube. The spin
column was removed from the tube, and the plasmids were stored in the freezer at -
20°C.
UV--Visible Spectroscopy: Plasmid Analysis
In order to determine the concentrations of purified plasmids, UV-Vis
spectroscopy was used. DNA has a distinct absorbance pattern, with a peak at about
260nm and relatively no absorbance at 350nm. Measuring the absorbance at 350nm
is a way to subtract the background noise from the spectrum and obtain a more
accurate concentration. The spectrum was obtained with a minimum wavelength of
200nm and a maximum of 400nm. Before running the plasmids, the instrument
baseline was zeroed using a microcuvette with 80µl of distilled water. This blank is
run a second time to ensure there are no peaks in the spectrum (i.e., the baseline is
properly zeroed). The samples were then diluted 20-fold, meaning 4µl of the
plasmid was added to 76µl of distilled water. The samples were flicked to mix, then
spun down for about 10 seconds in a microcentrifuge. The samples were then
placed in the same microcuvette used to run the blank and the absorbance values at
260nm and 350nm were recorded. Before adding each sample, it was important to
be sure that the entire previous sample had been removed from the cuvette to
ensure a more accurate concentration reading. These concentrations were then
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added to a spreadsheet with the concentration values for all of the DNA mutants.
The spreadsheet was set up to automatically calculate the concentration of the
plasmid DNA sample using the absorbance at 260nm and 350nm.
Sequence Analysis
The purified DNA was diluted to a specific concentration and sent to Iowa
State University to be sequenced. The sequence results were sent through an online
account, and they were interpreted using the viewing program called Chromas and
an online gene database and alignment program called BLAST. By comparing the
modified DNA to the original DNA in the database, the success of the mutation was
determined. If the new amino acid sequence was incorporated to the template DNA,
the next set of experiments could proceed.
Protein Purification
Successfully mutated DNA was then combined with a different strain of E.
coli, BL21(DE3), which is used for expressing protein. The transformation
procedure is the same as it is for the other strain of E. coli, with the cells sitting on
ice for 30 minutes, followed by heat shock, the addition of SOC media, and an hour-
long incubation on the shaker. The cells were then added to two plates per sample
and put in the incubator overnight. The liquid cultures prepared for these samples
were done on a much larger scale. Instead of 10mL volumes of media, a new kind of
flask was used. These large plastic flasks were called Fernbach flasks, and they were
used for large liquid cultures. For each Fernbach flask, 2xYT media was prepared
directly in the flask. The 2xYT media consisted of 16g tryptone, 10g yeast extract, 5g
of NaCl, and 1000mL of deionized water. This was then autoclaved for 20 minutes to
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sterilize the media. The flasks were labeled and 1.5mL of 100ng/µl ampicillin was
added to each flask. Instead of touching a single colony to a toothpick to inoculate
the flasks, the entire plate of colonies was added. This was done by suspending the
colonies on the plate using 3mL of LC media and a glass spreader. The spreader was
sterilized between each sample using a flame and ethanol. The liquid on the plate
was then pipetted off and placed in the flasks, and the flasks were put in a large
shaker set at 200rpm and 37°C, overnight. If the samples created a large amount of
foam, some antifoam solution was added to make the protein samples easier to
pour. The protein was poured into a Nalgene centrifuge bottle, about ¾ of the way
full, and it was centrifuged for 10 minutes at 5,000rpm and 4°C. The samples were
then removed from the centrifuge and the liquid was poured into a waste flask. The
process was repeated until all of the culture flasks were empty. This left behind a
cell pellet containing the protein of interest.
Once the cells pellets were isolated, the cells needed to be lysed. This is
essentially breaking apart the cells in order to have access to the protein of interest.
The components for a cell lysis were 10x BugBuster, Tris lysis buffer, and Benzonase
nuclease. The BugBuster is a detergent-like solution that breaks the cells apart.
These three components were mixed in volumes that corresponded to the size of the
cell pellet, and the pellets were placed on an orbital shaker to agitate them until
there was no solid left in the bottle. This process typically took about one hour. An
additional option to ensure complete lysis was sonification, the use of intense sound
waves that further broke the cells apart. However, this proved to have little
additional effect on the overall lysis process and was not used for every purification.
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After cell lysis the pellets were spun down in the centrifuge for 30 minutes at
10,000rpm and 4°C to remove the insoluble material from the sample, which
includes cell membranes and any associated proteins.
After removing the bottles from the centrifuge, the protein of interest was
obviously apparent in the liquid above the pellets, as the liquid was red. The
supernatant was poured out into graduated cylinders in order to measure the
volume. Once the volume was known, the liquid was transferred into an Erlenmeyer
flask, and placed on a stir plate. Ammonium sulfate salt was added slowly to a total
amount of 0.26g for every mL of protein. The mix was left on the stir plate and then
moved into the refrigerator overnight. After one night, the flasks were taken out of
the refrigerator and poured back into Nalgene bottles which were balanced and
centrifuged for 30 minutes at 10,000rpm and 4°C. This created a small pellet, with
the protein of interest being in the supernatant. While the supernatant was brighter
pink, the small pellet containing unwanted proteins was generally white to pale
pink.
The centrifuged liquid was then poured into dialysis tubing, which is used to
filter out only certain molecules. A knot is tied at one end of the tubing and the
protein is poured in the other. The top is twisted and clamped shut, and the dialysis
bag is placed in a large jar of dialysis buffer. This is placed on a stir plate and stored
in the cold room overnight. Because only select molecules can pass through the
dialysis membrane and into the buffer, the protein stayed trapped in the tubing,
while small molecules crossed the membrane and flowed into the buffer. This
method was used to drastically reduce the concentration of ammonium sulfate in
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the sample. After one night, the protein in the dialysis bag was removed from one jar
of dialysis buffer and placed in a second, fresh buffer for further dialysis. It was
again placed on a stir plate in the cold room (4°C) and left overnight.
Once the protein had been in dialysis buffer for two nights, it was centrifuged
for 30 minutes at 10,000rpm and 4°C. Again, the protein of interest stayed in the
supernatant, which was bright red. At that point the samples were ready for ion-
exchange column chromatography. This is a method that can separate one protein
from the remaining cellular components based on the charge on the protein. CM
(carboxymethyl) Sepharose resin is made up of tiny beads, and different proteins
will associate with the beads for different lengths of time depending on their charge.
A buffer is rinsed through the column, and protein will begin to elute based on the
salt concentration of the buffer, as a high concentration of ions in the solution will
disrupt the interaction between the protein and the resin. The concentration of the
buffer is slowly increased, and eventually it is high enough to elute the protein of
interest, which has a distinct red color.
The supernatant from the final centrifuge run was poured into a 1L flask
containing CM-Sepharose resin that was previously equilibrated in CM-Low buffer.
CM-Low buffer is a low salt buffer that will allow the cytochrome c protein to stick
to the resin. The protein-resin mixture was stored in the refrigerator for about one
hour in order to let the protein associate with the beads. The resin was then poured
into a glass column and rinsed with CM low buffer for approximately one hour to
wash off any proteins that did not stick to the resin.
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Once the chromatography column had been washed, a gradient mixer was set
up. This device consisted of two tubes, which had a small opening between them.
One tube had CM-Low buffer, and the other had CM-High buffer. The CM-High buffer
contains a high concentration of sodium chloride. The tube with the CM-Low buffer
had an additional opening that was connected to the chromatograpy column. As the
CM-Low buffer began to drip into the column, the reservoir holding the CM-Low
buffer would be depleted, and in order to maintain the volume balance in both
reservoirs, the CM-High buffer would automatically start to leak into the CM-Low
reservoir. In this way, the concentration of the buffer was gradually increased. The
buffer that flowed through the column was collected in a waste beaker, until the
distinct color of the protein was observed to drip out the bottom. At this time, the
waste beaker was replaced with a collection beaker, and the protein was collected
until no more of the protein color could be observed on the column. At this time, the
waste beaker was replaced and the concentration gradient was allowed to run its
course. This ensured that any remaining impurities from the sample would be
washed off with the CM-High buffer and the column resin could be reused. The
column was then re-equilibrated with CM-Low buffer and the resin was unpacked
from the column into a 1L flask and stored in the refrigerator at 4°C.
Once the protein had undergone purification by chromatography, the final
step in the process was protein concentration. This was done using a centrifuge and
Centricon concentrators, which are special centrifuge tubes with two
compartments: an inner chamber and an outer chamber. The compartments were
separated with a filter that allowed buffer to pass through to the inner chamber,
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while the larger protein molecules would be stuck in the outer chamber. The tubes
were centrifuged for 30 minutes at 3,000rpm and 4°C. The liquid in the inner
chamber was inspected to make sure it was colorless and no protein had escaped
through the filter, then it was disposed of. This process was repeated until the entire
protein sample had been concentrated. Once this had been completed, the protein
was diluted with HPLC A buffer and centrifuged. This process is referred to as a
buffer exchange, and it is done to ensure that all of the CM-High buffer had been
washed away, because the high salt concentration in the buffer can damage the
protein over longer time periods, or it can interfere with subsequent experiments.
Once the protein had been re-concentrated after the buffer exchange, the proteins
were divided into 1mL aliquots in 1.5mL tubes. The tubes were flash-frozen using
liquid nitrogen, then stored in the freezer at -80°C.
Dialysis Buffer Preparation
In order to prepare the buffer solution for dialysis, the following components
were weighed and put in a large glass jar (enough to hold about 2750mL of
solution): 1.72g NaH2PO4•H2O (monobasic), 3.11g Na2HPO4 (dibasic), and 1.08g
Na2EDTA. The jar was placed on a stir plate with a magnetic stir bar, and 2600mL of
deionized water was added. Once all of the solid was dissolved the pH was adjusted
to about 7.2 using either NaOH or HCl. The volume of the acid/base solutions used
to adjust the pH was added to the total volume, and the rest of the water was added
until the total solution volume was 2744mL. The final pH was taken and slight
adjustments were made with acid and base to ensure the solution was at about pH
7.2. The buffer was stored in the cold room at 4°C until used for the protein
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purification. Directly before using the dialysis buffer, 385µl of beta-
mercaptoethanol, or BME, was added to the solution. It is best to add BME directly
before using the buffer because it will be more effective, as it reacts with oxygen
over time.
HPLC Buffer A Preparation
The HPLC Buffer is used in the protein purification process. To prepare a one
liter volume, the following components were combined: 2.97g NaH2PO4•H2O
(monobasic) and 4.04g Na2HPO4 (dibasic). The powders were weighed out and
placed in a 2 liter beaker with a magnetic stir bar on a stir plate. 900mL of distilled
water was added and the powders were dissolved. The pH was adjusted to 7.0 using
a pH probe and solutions of NaOH and HCl. Once the pH was correct, the solution
was brought up to a total volume of 1 liter. The pH was checked one final time and
slight adjustments were made if necessary to maintain a pH of 7. The solution was
stored in the cold room at 4°C.
UV--Visible Spectroscopy: Protein Analysis
In order to analyze the final protein product, UV-Vis spectroscopy was used.
The iron in the heme of cytochrome c is found in either the +2 or +3 oxidation state,
and each of these states absorbs different wavelengths of light. Because the
oxidation state of the iron is an indicator as to whether the ligand switch has
occurred, this spectroscopic analysis was a good indicator of how specific mutations
in protein structure affected overall protein function.
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SDS--PAGE
Denaturing polyacrylamide gel electrophoresis (SDS-PAGE) was used in
order to separate proteins of different sizes. When a cell pellet was produced with a
brown or tan color not normally associated with cytochrome c expression, the
proteins in the cell pellet were denatured and run on a gel along with purified
cytochrome c as a control. If the band associated with cytochrome c matched a band
of protein in the newly harvested cells, it showed that the new sample successfully
expressed the protein of interest.
There were several components that needed to be prepared for an SDS-
PAGE. First was the Sample Buffer. This involved mixing 3.55mL of water, 1.25mL of
0.5M Tris•HCl (pH 6.8), 2.5mL of glycerol, 2.0mL of 10% SDS, and 0.1mg of
bromophenol blue. The next component that needed to be prepared was the 15%
Separating Gel. This was the main gel component that the protein would be
separated in. The following components were added: 1.2mL of distilled, de-ionized
water, 2.5mL of 30% acrylamide/0.8% bis-acrylamide solution, 1.25mL of buffer
(1.5M Tris•HCl, pH 8.8), and 0.05mL of 10% SDS. The final component to be
prepared was the 6% Stacking Gel. This gel was poured on top of the Separating Gel.
This is the gel that the samples are actually added to, and it allows the protein to
form a uniform band before actually hitting the separating gel. To prepare it the
following components were combined: 0.5mL 30% acrylamide/0.8% bis-acrylamide
solution, 0.65mL of buffer (0.5M Tris•HCl, pH 6.8), 0.025mL 10% SDS, and 1.325mL
water.
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The gel plates were assembled. These were two thin glass plates that the gels
would be poured into and solidified in. The first gel to be added was the Separating
Gel. Before adding it to the gel plates, 30µl of 1% (w/v) ammonium persulfate, or
APS, and 10µl of TEMED were added to the gel solution. These caused the gel to
begin to polymerize, which would allow it to eventually retain a solid shape.
Immediately after adding the APS and TEMED, a glass pipet was used to suck up the
gel mixture and put it in between the two glass plates. The gel sat for a few minutes,
and a layer of water was added to the top of the plates to help even the top of the gel
out. The water was poured out, and the same process was used to add the Stacking
Gel, this time using 13µl of 1% (w/v) APS and 3µl of TEMED. A comb was inserted at
the top of the gel plates to form the wells for the protein samples, and the gel was
allowed to solidify.
The cell pellets were dissolved in sample buffer and the denatured protein
samples were heated and spun down in order to prepare them for the gel. An
electrophoresis tank was set up, and the gel was placed inside. The comb was
removed and the inner chamber was filled with 1x Running Buffer. Each well was
rinsed with about 50µl of running buffer using a syringe. The syringe was then used
to load the samples, rinsing with water between each one. Once the samples were
loaded, the remaining running buffer was poured into the tank and the lid was
placed on. The lid had leads that were plugged into the power source, matching like
colors. The gel was run at 200V and 100mA for about 45 minutes. Once the
bromophenol blue dye was close to running off the bottom of the gel, the power was
turned off. The gel was removed from the tank and the glass plates were pulled
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apart. A small razor was used, first to remove the stacking gel, and then to cut a
corner in the gel in order to identify when the gel was in the proper orientation.
The next step was to stain the gel so the protein bands could be identified.
The gel was first rinsed with a small amount of tap deionized water to remove any
adhering buffer. A flat glass bowl was used to pour in a layer of blue stain around
0.5-1 inches deep. It was microwaved until hot. The gel was placed in the stain for
about 40 minutes, then removed and rinsed with water. A 10% acetic acid destain
solution was microwaved until warm, and the gel was placed in it to de-stain. Kim-
wipes were placed in the container and weighed down in order to absorb the dye.
The gel was placed on a slow moving shaker overnight. This process removed excess
dye from the gel, which left only the dye associated with the protein bands. Once the
gel had been de-stained, it was rinsed with de-ionized water, then placed in fresh
water on the slow moving shaker for about one hour. The water was removed and
replaced with a 30% methanol solution for an additional hour on the shaker to
slightly dehydrate the gel. The gel was placed between two sheets of drying film on a
drying frame, which was clamped together and left overnight. The dried gel was
then cut out of the frame and placed under a heavy object to help flatten of the gel.
The gel was then ready to be analyzed and stored.
Experimental Timeline
DNA Mutations
Before beginning the overall procedure for this research, it was important to
understand the nomenclature for the protein samples. The proteins are given a
variety of mutations at specific places in the amino acid sequence. A protein with no
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mutations is given the designation WT, which stands for wild-type. The proteins
used for this project were given several standard mutations (K72A and C102S), and
were therefore given the designation of WT*. For each mutation that was made, the
letter corresponding to new amino acid, as well as the position in the amino acid
chain, was added to the name. For example a protein with the name WT*/A73 was
mutated to have an alanine in the 73rd position of the protein chain, and a protein
named WT*/A73/C80 had a mutation to alanine at the 73rd position and a cysteine
at the 80th position.
The first stage of the experiment consisted of mutating several strains of DNA
to have a cysteine at position 80 of the amino acid chain. In cytochrome c, the 80th
amino acid, which is normally methionine, is attached to the heme, so it is important
that this matches real Type II proteins for the model to be valid. Two different
strains of parent DNA were used for this initial experiment: WT*/H73 and
WT*/A73. The primers used were K79/M80C and K79/M80Cr. The M80C indicates
that the parent DNA has a methionine in the 80th position, and it will be mutated to a
cysteine. The second primer has a lowercase “r,” indicating that it is the reverse
primer for the mutation. Both a forward and reverse primer are necessary for the
PCR reaction. The parent DNA was diluted to a concentration of 100ng/µl, and the
primers were diluted to concentrations of 125ng/µl. The PCR mix listed on the
following page was created:
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Table 2: PCR Mix
Component
Sterile Water
10x Pfu Buffer
10mM dNTPs
Parent DNA
Forward Primer
Reverse Primer
Pfu Ultra Polymerase Enzyme

Amount (µl)
41
5
1
1
1
1
1

Before mixing the reaction components, the Pfu buffer, dNTPs, DNA, and
primers needed to be thawed and spun down in a microcentrifuge to be mixed. After
the Pfu Ultra Polymerase enzyme was added, the solution was flicked to mix, then
spun in the microcentrifuge for about one minute to get rid of any air bubbles that
had formed in the tube. The total reaction volume was 51µl, and the “Cherney”
mutagenesis method was used on the thermocycler. Once the PCR was complete, 1µl
of Dpn1 endonuclease was added and the sample was placed in a 37°C water bath
for one hour. This digested the parent DNA. The samples from the reaction were
labeled WT*/A73/C80 and WT*/H73/C80.
After the DNA had been mutated in the PCR, it was necessary to do a
transformation to incorporate the new DNA into cells. The cells used was a 50µl
aliquot of the strain DH5α. In addition to the WT*/A73/C80 and WT*/H73/C80
from the PCR, three additional mutants were transformed: WT*, WT*/A73/A79, and
WT*/A73/H79. These three strains had been mutated previously and were stored in
the freezer at -20°C. For this transformation, 10µl of cells were combined with 3µl of
DNA in five separate 1.5mL sterile tubes. The above heat shock transformation
procedure was followed, and the cells were incubated overnight. WT*/A73/A79 and
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WT*/A73/H79 both grew over 100 colonies per plate, but the WT* and the two
mutants from the PCR did not grow any colonies on either plate.
Because the transformation was not successful, the PCR was repeated for
WT*/A73/C80 and WT*/H73/C80. New dilutions of the parent DNA and primers
were prepared, and new buffer was used as well. For the actual reaction, the
annealing temperature was lowered from 55°C to 53°C, because in some cases a
slightly colder annealing temperature makes it easier for the primers to bind to the
DNA. In addition to repeating the PCR, the original PCR mix from the first
experiment was used to repeat the transformation for these two mutants, as well as
WT*. 16.6µl of cells and 5µl of DNA were used for each sample. After incubating
these samples overnight, colonies grew on all four WT*/A73/C80 and
WT*/H73/C80 plates. No colonies grew on the WT* plates, but the original
transformation plates for the WT* mutant had been left out at room temperature in
an attempt to grow colonies, and one colony had grown on one plate. Because the
second transformations were successful, the DNA from the second PCR was not
needed, and it was stored at -20°C.
The following 10mL liquid cultures were prepared for the transformed cells:
Table 3: Liquid Culture Information
Mutant
WT*/A73/A79
WT*/A73/H79
WT*/A73/C80
WT*/H73/C80
WT*

Number of Cultures
1
1
3
3
1

25

Extra liquid cultures were made for the cells containing DNA that had just
been mutated with PCR, because the PCR reaction does not have a 100% success
rate. Some of the cells will take in new DNA with a sequence equivalent to the
original parent DNA, so taking several liquid cultures increases the chances that the
correct DNA will be found. Because the WT* plate had only one colony, the tip of a
sterile toothpick was used to spread the edge of the colony across the plate, in an
attempt to grow slightly more bacteria. This toothpick was then used in the liquid
culture. The cultures were prepared using the procedure outlined above and left to
shake overnight. The next day, the liquid, which had initially been clear, had a
cloudy appearance that indicated the cultures grew successfully.
After shaking overnight, the cells were ready for plasmid purification. This
procedure involved lysing the cells and extracting and purifying the plasmid. The
cultures were removed from the shaker and placed on ice. They were spun down in
a centrifuge so the cells were collected in a small pellet and the supernatant was
poured off. The plasmids were purified using the Wizard Plus SV Minipreps DNA
Purification System. The full purification procedure is described in detail above.
Once the plasmids were purified, they were diluted 20-fold in order to determine
their concentrations by UV-Visible spectroscopy. These concentrations were added
to a spreadsheet database that contained plasmid information for all mutants.
While preparing the WT*/A73/C80 and WT*/H73/C80 mutants, two
mutants that had been in storage at -20°C were prepared to be sent to Iowa State
University to be sequenced. These samples were WT*/A79/C80 and WT*/H79/C80,
with three samples for each mutant. The samples were prepared by making 5µl
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solutions with a concentration of 250ng/µl. The dilutions were done with sterile
water. The tubes were flicked to mix, spun down in the centrifuge, and wrapped in
Parafilm in order to ensure that the tubes remained sealed during shipment.
After the DNA had been sequenced, the information was sent to an online
account and available for downloading and analyzing. The mutation of interest was
a change in the three base pairs that code for the 80th amino acid in the protein. The
expected change in base pairs was ATG to TGC. Sequence documents were
generated for each sample, and the computer program BLAST was used to compare
the sample to the original DNA so the success of the mutation could be identified. As
long as one of the three samples had an intact plasmid with the correct mutation,
the PCR was considered a success. WT*/A79/C80 had one sample with the correct
mutation, but all three of the samples for WT*/H79/C80 were incorrect, meaning
the sequence analysis showed that the sample contained only the original parent
DNA, and did not have the cysteine mutation at the 80th amino acid position.
In order to attempt to get a sample with the correct mutation, three more
liquid cultures were started for WT*/H79/C80 from the plates that had been stored
in the refrigerator at 4°C. These cultures were then harvested, the DNA was purified
and the DNA concentration was found with UV-Vis spectroscopy. These samples
were then prepared for sequencing along with the six WT*/A73/C80 and
WT*/H73/C80 samples.
Once the sequence results were analyzed, it was found that two out of the
three WT*/A73/C80 plasmids were correct, but none of the WT*/H73/C80 or
WT*/H79/C80 mutations had worked. Because the WT*/H79/C80 mutant had
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failed six times, the PCR was repeated. In this reaction, the annealing temperature
was lowered from 55°C to 53°C. After the reaction in the thermocycler, the Dpn1
enzyme was added and the tube was placed in the water bath for 2 hours. A second
PCR had already been run for the WT*/H73/C80 mutant. Both of these samples
were transformed, adding 25µl of cells to 7µl of DNA in 1.5mL sterile tubes. The
above transformation procedure was followed. After incubating overnight,
WT*/H79/C80 had many colonies; WT*/H73/C80 had a total of three colonies.
Three liquid cultures were made for each cell type. Since the WT*/H73/C80
mutant only had three colonies to begin with, each colony was streaked across the
plate in an attempt to get a little more cell growth. These plates were left out at
room temperature overnight, while the other two plates were wrapped with
Parafilm and stored at 4°C. Once the liquid cultures had been incubated, the
plasmids were purified, the DNA concentrations were measured using spectroscopy,
and the samples were diluted and prepared for sequencing.
The samples were sent to Iowa State, and the sequences were downloaded
and analyzed. WT*/H73/C80 had no correct sequence; it was all parent DNA, but for
WT*/H79/C80, one sample had the correctly mutated sequence. The PCR was
repeated for WT*/H73/C80 until the correct mutation was obtained. At this time
another PCR reaction was set up to add the C80 mutation to two additional DNA
mutants: WT* and WT*/A73/H79. These samples were prepared but did not need
to be sequenced at the time, so they were stored at -20°C.
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Protein Purification
Before working with the proteins that had the C80 mutation, several other
proteins were purified to be used as controls. These variants had been previously
transformed and stored at -80°C as protein pellets. The following table gives the
names of the variants used for purification, along with the mass of the protein pellet.
BL21(DE3) is the strain of E. coli cells used for the transformation process.
Table 4: Control Protein Pellets
Pellet Name
BL21 WT*/H73 1
BL21 WT*/H73 2
BL21 WT*/H79 1
BL21 WT*/H79 2
BL21 WT*/A79 1
BL21 WT*/A79 2
BL21 WT*/A73 1
BL21 WT*/A73 2

Mass(g)
9.365
9.415
7.67
8.31
7.479
7.97
7.31
7.87

Because the pellets had been stored at -80°C, they needed to undergo several
freeze/thaw cycles before beginning the purification process. For the first cycle, the
pellets were placed in the refrigerator, but the complete thaw took almost seven
hours. So from that point on the freeze/thaw cycles were done by placing the bottles
with the cell pellets in them in a large beaker of cool water. This was placed on a stir
plate until the pellets were runny, then the pellets were placed back at -80°C to
refreeze. Typically three freeze/thaws were done for each pellet. The pellets were
then ready for purification.
Only four samples were chosen for purification at first: WT*/H73 1 and 2, as
well as WT*/H79 1 and 2. The full details of the purification process can be found in
the methodology section. After cell lysis, the tubes of cell lysate were centrifuged.
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The volumes of cell-free lysate were combined, so there was only one WT*/H73
protein sample and one WT*/H79 protein sample. The volumes of supernatant for
the WT*/H73 and WT*/H79 variants were 97.5mL and 79.8mL, respectively. The
samples underwent the ammonium sulfate addition and two nights of dialysis
before they were ready for the column chromatography. At this point the
supernatant was a vivid pink in color.
Upon the addition of the column and the initial wash with CM-Low buffer, it
was found that both proteins began to elute, meaning the concentration of the CM-
Low buffer was already too high. A 1:1 dilution was made of the buffer in water, so
the concentration could be low enough to rinse the column without eluting the
proteins. It is undesirable for the proteins to elute immediately, because there
would be no separation of the impurities that are bound more weakly to the column.
WT*/H73 was a pale red-orange color, and WT*/H79 was pale red. The proteins
were then concentrated, and both variants turned a deep red color.
For each protein, 4µl was taken and diluted in 76µl of HPLCA buffer in order
to obtain a UV-vis spectrum. The spectra showed that the total protein yield for
WT*/H73 was 53.3mg and the yield for WT*/H79 was 27.0mg. The samples were
then divided up into aliquots, frozen in liquid nitrogen, and stored in the freezer at -
80°C. Following the purification of these two samples, the remaining proteins were
purified.
At this time, successful PCR had created several C80 mutants, and four were
chosen for purification: WT*/C80, WT*/A73/H79/C80, WT*/H73/C80, and
WT*/H79/C80. The DNA was transformed, and all variants except WT*/H79 had
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colonies. The other three variants were added to the large liquid cultures, two for
each plate (a total of six cultures) and incubated overnight. The next day, the two
cultures for each variant were combined and centrifuged until only a solid protein
pellet was left. The final mass of each pellet was measured. WT*/C80 and
WT*/H73/C80 had darker brown pellets with a slight red tint, while
WT*/A73/H79/C80 had lighter brown pellets. The pellets were stored at -80°C.
Two variants, WT*/C80 and WT*/H73/C80 were chosen to be purified
because they had a promising darker color. The freeze/thaw cycles were done by
thawing with a large beaker full of water on a stir plate, followed by a freeze in
liquid nitrogen for about one minute. The pellets were then lysed and centrifuged.
The full methodology for the protein purification process can be found above. The
total volumes for the cell-free lysate of WT*/C80 and WT*/H73/C80 were 90.9mL
and 88.1mL, respectively. This was followed by ammonium sulfate addition, dialysis,
and column chromatography. The protein that had been purified previously had a
pinker color to it, but because of the addition of the C80 mutation, these variants
were a darker brown in color with a slightly orange tint. The proteins were
concentrated, divided into aliquots, and placed in the fridge.
Protein Analysis
Once several proteins with the C80 mutation had been purified, it was
possible to test their behavior under various conditions using UV-Visible
spectroscopy. There are two distinct spectra that can be obtained: one occurs when
the iron in the heme is in an oxidized state, the other when the iron is in a reduced
state. The change from an oxidized to reduced state is also indicative of a ligand

31

switch occurring, so the changes in the spectra from oxidized to reduced was the
method used to determine whether or not the protein was undergoing the ligand
switch when exposed to various environments.
The first factor to be tested was the effect of pH on the protein’s ability to
ligand switch. Three different buffers were prepared: a MOPS buffer at pH 7.0, and
two Boric acid buffers, one at pH 9.0 and one at pH 10.0. The first protein to be
tested was WT*/H73/C80, diluted 15-fold by adding 16µl of the protein to 228µl of
the buffer for a total volume of 244µl. One dilution was made for each buffer. The
UV-Vis spectrophotometer was blanked using a water sample, and each buffer was
then run without any protein to be sure that there would be no significant peaks
caused by the buffer itself.
The samples were then run. Each sample was in an oxidized state for the
initial sample run (Figure 4). The next step was to see if a reducing agent could be
added to induce the ligand swith. A small amount of sodium dithionite, or DTH, was
added to each sample and a second spectrum was taken immediately after the
reducing agent was added. This step was done quickly in case the oxygen in the air
was enough to reoxidize the sample before an accurate spectrum could be taken.
Initially a rubber septum and nitrogen line was used in an attempt to clear oxygen
from the air space in the cuvette, but it was determined that this step was
unnecessary as long as the second spectrum was taken immediately after the DTH
was added. All three samples were reduced, showing a successful ligand switch.
Next, the WT*/C80 samples were prepared with the same 15-fold dilution
and final sample volume. The spectra were taken, and a small amount of DTH was
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added (Figure 5). All three samples were reduced. This was unexpected. The
WT*/C80 was supposed to act as a negative control at this stage in the experiment,
because it did not have an H73 or H79 mutation. Without a mutation in these spots
of the protein, it was expected that the protein would not be reduced, because it
would have nothing to ligand switch with. The fact that the WT*/C80 protein was
able to be reduced meant that it had in fact undergone a ligand switch, even though
there shouldn’t have been any nearby amino acids for the switch to occur. This
variant was tested further by using a micropipette to blow air into the samples. A
third spectrum was taken for each, and all three had been re-oxidized. The
reversibility of the ligand switch was tested even further by adding more DTH to the
pH10.0 sample. A fourth spectrum showed that the protein was able to reduce for a
second time. The line in this spectrum had shifted up slightly, possibly from the
protein beginning to denature.
The proteins were then tested using more acidic buffers. At acidic pH some
amino acid side chains that may otherwise act as ligands would be protonated. If
some of the proteins could not be reduced at acidic pH it would elucidate more
about the amino acids acting as heme ligands. Three buffers were made using citric
acid, one at pH 4.0, one at pH 5.0, and one at pH 6.0. Slightly larger samples were
used this time: 24µl of protein to 342µl of buffer for a total sample volume of 366µl.
First the spectra were taken for WT*/H73/C80, with reductions using DTH
attempted at each pH. Each sample could be reduced. Reoxidation was attempted at
pH 4.0, but the sample became cloudy, and it was likely that the protein had
denatured. Next the spectra were taken for WT*/C80. Again, each sample could be
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reduced. The sample at pH 6.0 was reoxidized using air, and re-reduced with more
DTH, again demonstrating the reversibility of the ligand switch. The reoxidation was
attempted at pH 4.0 as well, but the protein appeared to denature.
After testing the variants with the C80 mutations, two variants without this
mutation were thawed from the -80°C storage: WT*/A73 and WT*/H73. These
samples were diluted 15-fold to the 366µl sample volume using the buffers at pH
7.0, 9.0, and 10.0. These samples all started out reduced, and all were able to be
oxidized with a few crystals of the oxidizing agent K3Fe(CN)6.
Protein Expression
Because WT*/A73/H79/C80 had light brown pellets, it was likely that it was
not expressing much cytochrome c, which has a red color to it. Several methods
were tested in order to determine if there was a better way to get more protein
expression out of the cells. A transformation was done for this variant, along with
WT*/H79/C80, WT*/A73/A79/C80, WT*/A73/C80, and WT*/A79/C80.
The first test for better protein expression was done with a small sample
culture containing 20mL of 2xYT media. Instead of using one colony per culture, a
toothpick was used to scrape a dense area of colonies off the plate so more cells
were added to the culture. The cultures were put in the shaker overnight. The next
day, the cultures were poured into 50mL plastic tubes and centrifuged for 10
minutes at 5,000rpm and 4°C. The pellets were removed from the centrifuge and the
media was poured out. All of the pellets were a very pale brown, with no obvious
red color.
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The next attempt at better protein expression involved the addition of iron to
the cultures, which has been known to aid in the expression of certain heme
proteins. A ferric stock solution was prepared by adding 0.541g of ferric ammonium
citrate and 0.541g of citric acid to 50mL of water. The liquid cultures were prepared
for each sample by adding 10mL of 2xYT, 10µl of ampicillin, and 10µl of the ferric
stock solution. A dense clump of cells was used to inoculate each culture. In addition
to the iron, the cells were incubated overnight at a lower temperature, 28°C. The
next day, the cells were centrifuged and the media was poured out, but the cell
pellets were still a very pale brown.
The third attempt at improving expression involved an even better media:
10mL of Terrific Broth, 10µl of ampicillin, and 10µl of the ferric stock solution. The
temperature of the shaker was set at 25°C, but the actual running temperature was
closer to 27-28°C. These cultures were centrifuged, and even though there was still
no red tint, the pellets were a slightly darker brown than before.
Once some darker pellets had been produced, an SDS-PAGE gel was run in
order to see if any cytochrome c was actually in the pellet. The samples used were
WT*/H73, WT*/A73 (as controls, because both of these samples were known to
have cytochrome c), WT*/C80, WT*/H73/C80, WT*/A79/C80, and WT*/H79/C80.
The final two samples were not purified protein, but small clumps of the cell pellet
from the Terrific Broth liquid cultures. The purified samples were prepared by
adding 20µl of sample to 20µl of running buffer. These were mixed, and the samples
turned a dark blue. Because the pellets were harder to dissolve for the gel, between
600-700µl of sample buffer was added to the small pellet, with vigorous vortexing to
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mix. There was a small amount of pellet that didn’t dissolve, but there was enough
to run the gel.
The full procedure for running an SDS-PAGE can be found in the
methodology section. Between 10 and 20µl of sample was added to each well. There
was enough room on the gel for several samples to have two wells, in which case
two different volumes were used to see if the sample size had an effect on the
results of the gel. Once the gel was stained, the bands could be analyzed to
determine which samples had a good amount of cytochrome c. It was found that the
unpurified cell pellets were mainly impurities, and did not have a detectable amount
of protein compared to the other control samples.
Determination of the Unknown Ligand
Because it was crucial to have a protein that could act as a negative control
and not undergo a ligand switch, it was essential to determine what the WT*/C80
protein was using as a ligand when the reducing agent was added. The first step was
to do additional PCR on the WT*/C80 and WT*/H73/C80 variants. Three additional
primers were ordered to mutate the DNA. The first two, H33N and H39Q, were
prepared in order to remove two additional histidines from the amino acid
sequence. This amino acid is the main one used for ligand switching in this model,
therefore removing the additional histidines may prevent the control protein from
ligand switching if they are in fact the cause of the protein’s ability to switch when
the reducing agent is added. The primer H33N will change the histidine at the 33rd
position to an asparagine, and the H39Q primer will change the 39th histidine to a
glutamine. The third primer, N52I is for adding a stabilizing mutation to the protein.
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It will change the asparagine in the 52nd position to an isoleucine, which adds more
durability to the overall protein structure. Once these primers were ordered, the
concentrations were found using UV-Vis spectroscopy.
The first mutation to be added was H39Q, making the new mutants
WT*/Q39/C80 and WT*/Q39/H73/C80. This primer was added to the PCR mix, the
cells were transformed with the PCR DNA, and liquid cultures of the cells were
started. The plasmids were purified and their concentrations were measured using
UV-Vis spectroscopy. The samples were then prepared for sequencing and sent to
Iowa State University. The results were analyzed, and it was found that one of the
samples for WT*/Q39/C80 was correct, while neither of the WT*/Q39/H73/C80
samples were correct. Two more liquid cultures were prepared for this mutant. The
plasmids were purified, the concentration was found using UV-Vis, and the samples
were stored at -20°C until they would be sent for sequencing.
Two new PCR were started, one to add the next mutation to WT*/Q39/C80,
making it WT*/N33/Q39/C80, and one to add a stabilizing mutation to
WT*/H79/C80, making it WT*/I52/H79/C80. Once the PCR was complete, cells
were transformed with the PCR DNA, and two liquid cultures were made from the
cells containing each mutant. The plasmid DNA was purified and the concentrations
were found using UV-Vis. These two mutants, along with WT*/Q39/H73/C80, were
prepared for sequencing and sent to Iowa State. The results were analyzed, and at
least one sample had the correct mutation for each mutant.
After the successful mutations for the previous three samples, two additional
PCR’s were set up. One was to add the N33 mutation to WT*/Q39/H73/C80, and
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one was to add the stabilizing I52 mutation to WT*/N33/Q39/C80. The new mutant
DNA was prepared by PCR, multiplied in DH5α cells, extracted, and prepared for
sequencing. The N33 mutation was unsuccessful, but the WT*/N33/Q39/I52/C80
mutant worked. Two more liquid cultures were prepared for the failed mutant, and
this time the sequencing showed that the mutation had been successful, creating
WT*/N33/Q39/H73/C80.
At this point several different mutants had been created. These mutants were
transformed into BL21(DE3) cells and the cell colonies were used to make either
large Fernbach flask cultures or smaller 10mL liquid cultures. Two additional SDS-
PAGE gels were run using small chunks of the pellets from the liquid cultures, in
order to determine which samples would be the best candidates for a protein
purification. It was decided that the red/brown WT*/I52/H79/C80 and the pale
WT*/N33/Q39/H73/C80 would be used.
The cells were lysed using the BugBuster method, and the cells were
resuspended. Instead of doing a full protein purification at this point, the suspended
cells were diluted and a UV-Vis spectrum was taken for each sample. Even though
there was considerable noise in the spectra due to the impurities of the samples, it
was determined that the darker pellet did have a peak indicative of the cytochrome
c protein, while the paler pellet had almost no peak. The lysis was repeated for a
third pellet, WT*/N33/Q39/I52/C80, which had an intermediate brown color. The
spectrum showed a smaller peak, but one that was noticeable enough to assume
that a protein purification would yield enough protein that the variants could be
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tested in order to determine if the mutations were successful at stopping the
negative control protein from ligand switching upon reduction.
The variant WT*/N33/Q39/I52/C80 was lysed and centrifuged, obtaining an
intital cell-lysate volume of 100.0mL. The protein was purified using ammonium
sulfate precipitation, dialysis, and column chromatography. At this stage the protein
was a pale orange/brown color. The protein was concentrated to a darker
orange/brown color, and a UV-Vis spectrum was recorded to determine the protein
yield, 6.77mg. The protein was divided into 0.5mL aliquots, frozen in liquid nitrogen,
and stored at -80°C.
In order to test the ligand switching ability of the protein, it was diluted using
the MOPS pH 7.0 buffer and the citric acid buffers at pH 6.0 and pH 5.0, because the
ligand switch was more likely to be stopped under acidic conditions. After adding
sodium dithionite to each sample, it was found that all three samples continued to
be reduced. A final sample was prepared at pH 4.0, but this sample was able to be
reduced as well. The negative control protein still had the ability to ligand switch,
meaning further manipulation of the protein structure was still necessary in order
to obtain a properly functioning negative control.

Results
The overall purpose of this research was to use cytochrome c to create a
workable model of Type II proteins in order to study the mechanisms by which they
undergo a ligand switch. An important step towards this goal was achieved by
mutating the amino acid attached to the heme of the protein into a cysteine, which is
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one of the defining features of this specific type of protein. The fact that this protein
was successfully mutated and created was a positive result in the overall progress of
this research project. However, an unforeseen problem arose in that the negative
control protein was able to ligand switch. The development of a negative control is
crucial for being able to study the mechanism of the ligand switch; therefore, the
majority of the project was devoted to looking for possible reasons as to why the
ligand switch was still occurring in the negative controls. Various mutations have
proven to be unsuccessful in eliminating the ligand switch ability of the negative
control; however, each potential ligand that is eliminated brings the overall goal of a
workable control closer. Overall, even though improvements have been made to the
model, the answer to the question of the unknown ligand switch remains unknown
at the conclusion of this project.

Discussion
Two other methods for getting rid of various ligands have promise in helping
with the protein development. The first is acetylation, which adds a blocking acetyl
functional group to the amino acid lysine, as well as possibly blocking the amino-
terminus of the protein. A small scale acetylation was attempted, but the protein
was still able to ligand switch. Still, it is possible that this is a technique that could be
better developed and attempted in the future to see if the results change. The
second method involves more PCR mutations of the protein in an attempt to get rid
of the amino acids capable of acting as heme ligands. Two potential sites of mutation
are the histidine at the 26th position, which had been ignored because its presence
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added stability to the structure of the protein, and the amino-terminus of the
protein. Because the amino terminal group has a nitrogen atom similar to the
histidine amino acid residues, there is a chance that the end of the protein is actually
the cause of the unwanted ligand switch. Mutations that cause a cyclizing effect of
the amino-terminus may prevent it from ligand switching.

Conclusion
The objective of this research project was to create a model protein that
could be used to study the mechanism of the ligand switch in Type II thiolate-ligated
heme proteins. Type II proteins are a diverse group and they have been implicated
in gas exchange, metabolism, and regulation of the circadian rhythm. There are
several that can be tied to various disease states, such as CBS, and learning how the
ligand switch controls protein activation and function could be crucial to learning
more about the protein as a whole. Because of the complexity of the proteins of
interest, a smaller, simpler model was to be created using cytochrome c. A
fundamental step was taken towards the creation of a valid model by mutating the
amino acid attached to the heme from a methionine to a cysteine. However, a
setback occurred when it was discovered that the negative control protein was able
to ligand switch as well. The remainder of the research was done in order to try and
determine what the negative control protein is using as a ligand. Although many of
the variables that could be causing this switch have been eliminated, the nature of
the ligand switch remains unknown at this time. Further research will be conducted
in order to determine the nature of this ligand switch, and once the negative control
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is identified it can be removed. Then other protein models with specific ligands can
be created and tested under varying environmental conditions. The information that
is gained from the simple protein model can then be applied to the ligand switch of
the more complex Type II proteins, and this will lead to a greater understanding of
how these thiolate-ligated heme proteins function.
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Figures

Figure 1: A model of heme; it is an iron bound by a porphyrin ring. The iron can
form six bonds total in a Type II protein: four with the nitrogens in the ring, and two
with the protein itself (above and below the plane of the image).
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Figure 2: Ligand Switch Mechanism in a Type II Protein, CooA. This protein has a
ligand switch that replaces the cysteine (Cys75) with a histidine (His77). This causes
the proline (Pro2) on the other side to dissociate, and that side of the iron is open to
bind carbon monoxide, which activates the protein and allows the bacterium to use
carbon monoxide for metabolic purposes.
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Table 1: Several known Type II proteins with their functions.
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Figure 3: A three-dimensional model of cytochrome c. The heme is in blue, and
several key amino acids are shown, including Cys80 (above the heme) and His73
(amino acid with the pentagonal structure).
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Figure 4: An example of a UV-Vis spectrum of WT*/H73/C80 at three different pH
values. This shows that pH had little effect on the heme ligation. The distinct shape
of the spectrum indicates that the heme is in an oxidized (Fe3+) state.
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Figure 5: The spectrum of WT*/C80. This shows the clear differences between an
oxidized (Fe3+) and reduced (Fe2+) state. This was unexpected for this variant,
because it should not have been able to ligand switch, and therefore was unlikely to
be reduced by the addition of sodium dithionite (DTH).
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